Helicobacter pylori cell membrane

The **Helicobacter pylori cell membrane** is a structural component of the bacterium *Helicobacter pylori*, comprising the inner (cytoplasmic) membrane, the peptidoglycan cell wall, and an outer membrane unique to Gram-negative bacteria[7][3]. This “envelope” contains specialized lipids such as cholesterol glucoside and supports numerous proteins that regulate shape, motility, host adhesion, immune evasion, and drug resistance[3][5][7]. While the cell membrane is not itself a unique molecular target, it provides the localization for essential membrane-associated proteins and is the main barrier targeted by various antibiotics and therapeutic nanoparticles. Selective targeting of the membrane often relies on disrupting its integrity or function to allow antibacterial agents access to intracellular targets[8]. However, the cell membrane as a whole is not considered a precise or canonical "therapeutic target" like an enzyme or receptor, making its designation as a specific drug target incorrect. **Notes:** - *is_incorrect* is true because “cell membrane” refers to a broad cellular structure, not a specific drug target or molecule as recognized in pharmacological or molecular biology contexts. - The actual drug targets within *H. pylori* are typically membrane-associated proteins, enzymes, or transporters localized in or spanning the membrane, not the membrane entity itself[2][6]. - Common therapeutic interventions attempt to exploit membrane permeability or use delivery vehicles (e.g., nanoparticles) to increase local antibiotic concentrations, but the “cell membrane” is not itself the canonical target[8].

Other names

H. pylori cell envelopeH. pylori membrane

Disruption of membrane integrity, Inhibition of cell wall/membrane synthesis, Increased permeability to allow drug entry